Fundraising September 15, 2024 – October 1, 2024 About fundraising

Phase II/III weeklynab-paclitaxel plus gemcitabine or...

Trials 2015 / 12 Vol. 16; Iss. 1

Phase II/III weeklynab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial

Yardley, Denise A., Brufsky, Adam, Coleman, Robert E., Conte, Pierfranco F., Cortes, Javier, Glück, Stefan, Nabholtz, Jean-Mark A., O’Shaughnessy, Joyce, Beck, Robert M., Ko, Amy, Renschler, Markus F.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Trials
DOI:
10.1186/s13063-015-1101-7
Date:
December, 2015
File:
PDF, 850 KB
english, 2015
Conversion to is in progress
Conversion to is failed